HC Wainwright & Co. Downgrades TRACON Pharma to Neutral
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. has downgraded TRACON Pharma from Buy to Neutral, as per analyst Edward White.
July 01, 2024 | 5:43 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
HC Wainwright & Co. has downgraded TRACON Pharma from Buy to Neutral, indicating a less optimistic outlook on the company's stock.
The downgrade from Buy to Neutral by a reputable analyst firm like HC Wainwright & Co. suggests a less favorable view on TRACON Pharma's future performance, which could lead to a short-term decline in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100